Li C, Zhang L, Zhang J, Jiao J, Hua G, Wang Y
BMC Med. 2024; 22(1):604.
PMID: 39736662
PMC: 11686879.
DOI: 10.1186/s12916-024-03827-9.
Woldeyohannes A, Wondimu B, Kefenie D, Legesse T, Issa S
Ethiop J Health Sci. 2024; 34(Spec Iss 1):39-46.
PMID: 39735524
PMC: 11674751.
DOI: 10.4314/ejhs.v34i1.7S.
Al-Haddad C, Wehbi Z, Slim A, Hmede A, Jurdi Kheir W, Saab R
Eye (Lond). 2024; 39(4):748-754.
PMID: 39562725
PMC: 11885430.
DOI: 10.1038/s41433-024-03465-8.
Ribeiro K, Veiga L, Carvalho Filho N, Morton L, Kleinerman R, Antoneli C
Int J Cancer. 2024; 156(1):69-78.
PMID: 39138799
PMC: 11537822.
DOI: 10.1002/ijc.35127.
Tanveer S, Zafar F, Bibi H, Haroon H, Ahmad O, Iqbal M
Cureus. 2024; 16(1):e53012.
PMID: 38410326
PMC: 10895558.
DOI: 10.7759/cureus.53012.
Treatment adherence in retinoblastoma: A retro-prospective cohort study in Ivory Coast and the Democratic Republic of Congo.
Lukamba R, Budiongo A, Monga B, Yao A, Bey P, Chenge G
Cancer Rep (Hoboken). 2023; :e1949.
PMID: 38146612
PMC: 10849925.
DOI: 10.1002/cnr2.1949.
Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes.
Kakarala C, Raval V, Mallu A, Rao R, Gavara S, Reddy V
Oman J Ophthalmol. 2023; 16(3):524-528.
PMID: 38059077
PMC: 10697251.
DOI: 10.4103/ojo.ojo_176_22.
Epidemiological and Clinical Presentation of Retinoblastoma among Nepalese Children in 2019.
Limbu B, Arjyal Kafle P, Lamichanne D, Pant S, Shakya S, Rasaily S
South Asian J Cancer. 2023; 12(2):199-205.
PMID: 37969676
PMC: 10635776.
DOI: 10.1055/s-0042-1757581.
Causes of death and survival analysis for patients with retinoblastoma in Jordan.
Bilbeisi T, Almasry R, Obeidat M, Mohammad M, Jaradat I, Halalsheh H
Front Med (Lausanne). 2023; 10:1244308.
PMID: 37731722
PMC: 10507250.
DOI: 10.3389/fmed.2023.1244308.
Retinoblastoma: present scenario and future challenges.
Byroju V, Nadukkandy A, Cordani M, Kumar L
Cell Commun Signal. 2023; 21(1):226.
PMID: 37667345
PMC: 10478474.
DOI: 10.1186/s12964-023-01223-z.
Health Services Needs Assessment for Retinoblastoma in Ethiopia.
Sherief S, Wu F, OBanion J, Teshome T, Dimaras H
JCO Glob Oncol. 2023; 9:e2200445.
PMID: 37348044
PMC: 10497293.
DOI: 10.1200/GO.22.00445.
Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.
Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F
Onco Targets Ther. 2022; 15:1545-1561.
PMID: 36579184
PMC: 9792108.
DOI: 10.2147/OTT.S370878.
EyeScreen: Development and Potential of a Novel Machine Learning Application to Detect Leukocoria.
Bernard A, Xia S, Saleh S, Ndukwe T, Meyer J, Soloway E
Ophthalmol Sci. 2022; 2(3):100158.
PMID: 36245758
PMC: 9560653.
DOI: 10.1016/j.xops.2022.100158.
Review: New horizons in retinoblastoma treatment: an updated review article.
Azimi F, Mirshahi R, Naseripour M
Mol Vis. 2022; 28:130-146.
PMID: 36034735
PMC: 9352364.
Anatomo-Clinical Aspects of Retinoblastoma: A Series of 144 Cases.
Da Silva F, Kora L, Elongo T, El Kebir A, El Maaloum L, Bennani-Guebessi N
Cureus. 2022; 14(5):e25422.
PMID: 35769683
PMC: 9234544.
DOI: 10.7759/cureus.25422.
Natural History of Untreated Retinoblastoma.
Zhao J, Feng Z, Gallie B
Cancers (Basel). 2021; 13(15).
PMID: 34359552
PMC: 8344972.
DOI: 10.3390/cancers13153646.
Eye Salvage with Intra-Arterial and Intra-Vitreal Chemotherapy in Patients with Retinoblastoma: 8-Year Single-Institution Experience in Colombia.
Gonzalez M, Gaviria M, Lopez M, Escudero P, Bravo A, Vargas S
Ocul Oncol Pathol. 2021; 7(3):215-223.
PMID: 34307335
PMC: 8280417.
DOI: 10.1159/000511980.
Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia.
Handayani K, Indraswari B, Sitaresmi M, Mulatsih S, Widjajanto P, Kors W
Asian Pac J Cancer Prev. 2021; 22(5):1613-1621.
PMID: 34048193
PMC: 8408394.
DOI: 10.31557/APJCP.2021.22.5.1613.
Modern treatment of retinoblastoma: A 2020 review.
Ancona-Lezama D, Dalvin L, Shields C
Indian J Ophthalmol. 2020; 68(11):2356-2365.
PMID: 33120616
PMC: 7774148.
DOI: 10.4103/ijo.IJO_721_20.
Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells.
Oronowicz J, Reinhard J, Reinach P, Ludwiczak S, Luo H, Salem M
Lab Invest. 2020; 101(1):70-88.
PMID: 32948812
PMC: 7758186.
DOI: 10.1038/s41374-020-00485-2.